Scarica l'app Stockscreener
20.63
0.42%
-0.0877
Dopo l'orario di chiusura:
20.63
-0.0009
-0.00%
Cartesian Growth Corp Borsa (GLBL) Ultime notizie
Berkley W R Corp Lowers Position in Cartesian Growth Co. II (NASDAQ:RENE) - MarketBeat
Cartesian Growth Corp II extends business combination period - Investing.com Australia
Opening Day: Smart Digital, Yuanbao make debuts - TipRanks
Gores Group's Latest SPAC Leads 3 IPOs Totaling $792M - Law360
Cartesian Growth Corp II extends business combination period By Investing.com - Investing.com South Africa
IPO NewsUS IPO Weekly Recap: Flurry of SPACs list and submit filings amid otherwise quiet IPO market - renaissancecapital.com
Cartesian Growth Corporation III Announces Pricing of Upsized $240 Million Initial Public Offering - Business Wire
Cartesian Growth Co. II (NASDAQ:RENE) Shares Sold by Crossingbridge Advisors LLC - MarketBeat
Spartan Fund Management Inc. Invests $295,000 in Cartesian Growth Co. II (NASDAQ:RENE) - MarketBeat
200,000 Shares in Cartesian Growth Co. II (NASDAQ:RENE) Acquired by Alpine Global Management LLC - MarketBeat
Cartesian Growth Co. II (NASDAQ:RENE) Trading Down 0%Time to Sell? - MarketBeat
Cartesian Robot Market to Grow at 7.1% CAGR, Valued at US$ 5.4 Billion by 2033 - openPR.com
Cartesian Growth Co. II (NASDAQ:RENE) Shares Down 0% – Time to Sell? - Defense World
Cartesian Warehouse Robotic Market will Touch New Development Level | ABB, KUKA, Fanuc, Yaskawa - newstrail.com
Cartesian Growth Co. II (NASDAQ:RENEU) Stock Price Down 0.4% – Should You Sell? - Defense World
RENE stock hits 52-week high at $11.89 amid market optimism - Investing.com Australia
Cartesian Growth Corp II extends business combination deadline By Investing.com - Investing.com South Africa
Cartesian Growth Corp II extends business combination deadline - Investing.com Australia
(RENE) Investment Analysis - news.stocktradersdaily.com
Brokerages Set Cartesian Therapeutics, Inc. (NASDAQ:RNAC) PT at $42.14 - Defense World
5 Hot Stock Buys for Investors in April - The Globe and Mail
Cartesian Growth Corp II SEC 10-K Report - TradingView
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Holdings Raised by Bank of New York Mellon Corp - Defense World
(RENE) Long Term Investment Analysis - news.stocktradersdaily.com
RENE stock hits 52-week high at $11.86 amid growth optimism - Investing.com India
RENE stock hits 52-week high at $11.86 amid growth optimism By Investing.com - Investing.com South Africa
Mizuho Securities USA LLC Increases Holdings in Cartesian Growth Co. II (NASDAQ:RENE) - MarketBeat
Cartesian Growth Co. II (NASDAQ:RENE) Shares Sold by Periscope Capital Inc. - MarketBeat
RENE stock hits 52-week high at $11.83 amid market optimism - Investing.com Australia
RENE stock hits 52-week high at $11.83 amid market optimism By Investing.com - Investing.com South Africa
Global Gantry (Cartesian) Robot Market Poised to Reach USD 23.4 Billion by 2031 Amid Rising Automation Trends - WhaTech
Cartesian Growth Co. II (NASDAQ:RENE) Short Interest Update - MarketBeat
Learn to Evaluate (RENE) using the Charts - Stock Traders Daily
Cantor Fitzgerald maintains Overweight on Cartesian Therapeutics - Investing.com
Cantor Fitzgerald maintains Overweight on Cartesian Therapeutics By Investing.com - Investing.com UK
Cartesian Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cartesian Growth Co. II (NASDAQ:RENE) Short Interest Down 25.0% in February - MarketBeat
0.41%
0.20%
Capitalizzazione:
|
Volume (24 ore):